MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis
MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis have?
MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis has 88 citations in the OpenAlex counts ScholarIQ stores.
When was MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis published?
MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis has 2016 year in the ScholarIQ index.
What is the open-access status of MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis?
MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis has green oa status in the ScholarIQ index.
What is the DOI of MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis?
The DOI for MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis is on the source record.
What is the PMID of MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis?
The PMID for MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis is on the source record.
What is the OpenAlex record for MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis?
The OpenAlex for MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis is on the source record.